Related Experiment Video
Updated: Oct 4, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Five-year outcomes of premature infants randomized to high or standard loading dose caffeine
Christopher McPherson1,2, Rachel E Lean3, Peppar E P Cyr4
1Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, USA. mcphersonc@wustl.edu.
Insights
A pilot study found that a high loading dose of caffeine citrate in very low birth weight neonates did not significantly impact 5-year neurodevelopment or socioemotional outcomes. Long-term follow-up showed no profound differences between high and standard dose groups.
Area of Science:
- Neonatal Medicine
- Developmental Pediatrics
- Clinical Pharmacology
Background:
- Preterm birth affects neurodevelopment.
- Caffeine is used to treat apnea in preterm infants.
- Optimal dosing strategies require investigation.
Purpose of the Study:
- To assess 5-year neurodevelopmental and socioemotional outcomes.
- To evaluate a high loading dose of caffeine citrate in very low birth weight neonates.
- To inform optimal caffeine dosing in neonatal care.
Main Methods:
- Pilot randomized controlled trial.
- 74 very low birth weight neonates randomized to high (80 mg/kg) or standard (20 mg/kg) caffeine loading dose.
- Standardized neurodevelopmental tests and parent reports at 5 years.
Main Results:
- 74% of survivors returned for follow-up.
- No significant differences in neurodevelopmental or socioemotional scores.
- No difference in neurodevelopmental delay after controlling for confounders.
Conclusions:
- High loading dose caffeine citrate did not profoundly impact 5-year outcomes.
- This pilot trial suggests safety and efficacy of standard dosing.
- Further research may explore individualized caffeine titration.
Objective:
To examine 5-year outcomes in children enrolled in a pilot randomized controlled trial of a high loading dose of caffeine after preterm birth.
Study Design:
Seventy-four very low birth weight neonates were randomized within the first 24 h of life to receive a high (80 mg/kg) or standard (20 mg/kg) loading dose of caffeine citrate. At 5 years of age, we conducted standardized neurodevelopmental tests and collected parent reports of child socioemotional problems.
Result:
Seventy-four percent of survivors returned for follow up. Children obtained similar scores on neurodevelopmental and socioemotional evaluations. There was no difference in the incidence of any neurodevelopmental delay after controlling for confounding factors.
Conclusion:
Five-year follow up of a pilot trial of high loading dose caffeine citrate documented no profound impacts on childhood neurodevelopment or socioemotional outcome.
Related Concept Videos
Drug Dosing: Infants and Children
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion

